SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation System, Endura, SPRINT Clinical Programmer Kit— 510(k) K181422

Substantially Equivalent

Spr Therapeutics, Inc.

FDA 510(k) clearance K181422 for SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation System, Endura, SPRINT Clinical Programmer Kit, Substantially Equivalent on 2018-07-31. Applicant: Spr Therapeutics, Inc..

Clearance details

Applicant
Spr Therapeutics, Inc.
Product code
Code NHI
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Cleveland, OH, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.